https://www.gcimagazine.com/companies/news/22970759/amid-portfolio-reset-este-lauder-names-communications-leader-to-boost-brand-desirabilityGlobal Cosmetic Industryen2026-07-17T13:54:46.000ZAmid Portfolio Reset, Estée Lauder Names Communications Leader to Boost Brand Desirabilityhttps://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/07/madeleine-boyd-b-w-portrait.0WZS8Ysmtj.jpg?auto=format%252Ccompress&q=70In her newly created role, Boyd will establish and lead a centralized global brand communications organization responsible for aligning communications across Estée Lauder's brands while developing a cohesive enterprise-wide strategy.https://www.gcimagazine.com/brands-products/skin-care/news/22970752/medik8-lands-in-sephora-as-loral-accelerates-clinical-skin-care-play-across-north-americaGlobal Cosmetic Industryen2026-07-17T13:33:37.000ZMedik8 Lands in Sephora as L'Oréal Accelerates Clinical Skin Care Play Across North Americahttps://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/07/fr-medik8-2026-ctetra-shaz1-hifi-3x4-1922-alt-2.DkzyybWXOd.jpg?auto=format%252Ccompress&q=70The retailer partnership comes as Medik8 targets more than £100 million in North American retail sales by 2029, with ambitions to become one of Sephora's top 10 skin care brands within the next three to five years.https://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/07/fr-medik8-2026-peptides-awourhero4-hifi-3x4-2645.WdCWFqWgm7.jpg?auto=format%252Ccompress&q=70The expansion significantly increases Medik8's accessibility in North America and underscores Sephora's efforts to strengthen its position in the fast-growing clinical beauty segment, where ingredient transparency, dermatologist credibility and clinically validated efficacy are increasingly influencing purchasing decisions.https://www.gcimagazine.com/brands-products/skin-care/news/22970667/the-melasma-race-heats-up-as-loral-brands-expand-melasylGlobal Cosmetic Industryen2026-07-16T14:44:02.000ZThe Melasma Race Heats Up as L'Oréal Brands Expand Melasylhttps://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/07/loreal-social-skin-lumiere-serum.KeUwCVvKzS.jpg?auto=format%252Ccompress&q=70For L'Oréal Paris, the emphasis is democratizing advanced pigment science.https://img.gcimagazine.com/mindful/allured/workspaces/default/uploads/2026/07/la-roche-posay-keke-x-lrp.yR51nFPZpX.jpg?auto=format%252Ccompress&q=70La Roche-Posay is positioning pigmentation as both a dermatological and emotional health issue. Its new Mela B3 Double Dose Discoloration Treatment contains 1% Melasyl alongside Proxylane to simultaneously target discoloration and visible signs of aging across the face, neck, décolleté and hands.